A small study of a treatment that stabilized four Alzheimer’s patients for three years is making big waves. It’s not often that a study of a drug being tested in fewer than two dozen people grabs the attention of top experts gathered for a major medical meeting. But that is what’s happening at the Alzheimer’s Association International [...]